tiprankstipranks
Trending News
More News >
Processa Pharmaceuticals (PCSA)
NASDAQ:PCSA
US Market

Processa Pharmaceuticals (PCSA) Income Statement

Compare
157 Followers

Processa Pharmaceuticals Income Statement

Last quarter (Q4 2024), Processa Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Processa Pharmaceuticals's net income was $-2.73M. See Processa Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -222.00$ -27.53M$ -12.13M$ -15.14M
Operating Expenses
$ 12.05M$ 11.46M$ 20.26M$ 11.57M$ 6.44M
Depreciation and Amortization
$ 0.00$ 222.00$ 874.01K$ 875.35K$ 882.06K
EBITDA
$ 0.00$ -11.46M$ -19.47M$ -11.08M$ -5.63M
Operating Income
$ 0.00$ -11.46M$ -27.53M$ -12.13M$ -15.14M
Other Income/Expenses
$ 0.00$ 335.54K$ 101.20K$ 175.40K$ -277.95K
Pretax Income
$ -11.85M$ -11.12M$ -27.42M$ -11.96M$ -15.41M
Net Income
$ -11.85M$ -11.12M$ -54.85M$ -11.43M$ -14.41M
Per Share Metrics
Basic EPS
$ -3.62$ -8.48$ -68.00$ -15.00$ -38.40
Diluted EPS
$ -3.62$ -8.48$ -68.00$ -15.00$ -38.40
Weighted Average Shares Outstanding
3.28M 1.31M 805.46K 765.97K 374.98K
Weighted Average Shares Outstanding (Diluted)
3.28M 1.31M 805.46K 765.97K 374.98K
Currency in USD

Processa Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis